FDA GRANTS ORPHAN DRUG DESIGNATION FOR TNFERADE(TM)
Sanofi-aventis and Wellstat Therapeutics enter into an Exclusive Worldwide Licensing Agreement for novel oral agent to treat Type II Diabetes
Strategic Collaboration with Kineta
ONCOLYS BIOPHARMA SIGN STRATEGIC ALLIANCE AND LICENSE AGREEMENT WITH ASTELLAS PHARMA TO DEVELOP AND COMMERCIALIZE YM753 HDAC INHIBITOR DRUG
The European Commission grants Orphan Drug designation for NGR-hTNF in the treatment of hepatocellular carcinoma
Champions Biotechnology Expands Collaboration to Test Oncology Therapeutic in Biomerk Tumorgrafts(TM)
PharmaGap Announces Completion of Securities Lending Arrangements with Stormont.
SRI International and F. Hoffmann-La Roche Launch Translational Medicine Collaboration to Study Methods and Treatments Associated with Cognitive Deficits across Neuropsychiatric Disorders
Novavax and Xcellerex Announce Collaboration to Develop Large-scale Manufacturing Process for 2009 H1N1 Influenza VLP Vaccine
Potentia Pharmaceuticals Enters into Licensing and Purchase Option Agreements with Alcon (October 2009)
Clients in focus...
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd All rights reserved. Terms and Conditions | Contact us